Loading...
RADL.Y logo

Raia Drogasil S.A.OTCPK:RADL.Y Stock Report

Market Cap US$5.7b
Share Price
US$3.34
US$5.28
36.7% undervalued intrinsic discount
1Y16.0%
7D-5.5%
1D
Portfolio Value
View

Raia Drogasil S.A.

OTCPK:RADL.Y Stock Report

Market Cap: US$5.7b

Raia Drogasil (RADL.Y) Stock Overview

Engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. More details

RADL.Y fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance2/6
Financial Health3/6
Dividends5/6

RADL.Y Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Raia Drogasil S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Raia Drogasil
Historical stock prices
Current Share PriceR$3.34
52 Week HighR$5.34
52 Week LowR$2.25
Beta0.019
1 Month Change-7.62%
3 Month Change-29.75%
1 Year Change16.04%
3 Year Change-42.67%
5 Year Change-21.23%
Change since IPO-11.22%

Recent News & Updates

Recent updates

Shareholder Returns

RADL.YUS Consumer RetailingUS Market
7D-5.5%-1.8%-2.3%
1Y16.0%11.4%21.2%

Return vs Industry: RADL.Y exceeded the US Consumer Retailing industry which returned 9.6% over the past year.

Return vs Market: RADL.Y underperformed the US Market which returned 23.3% over the past year.

Price Volatility

Is RADL.Y's price volatile compared to industry and market?
RADL.Y volatility
RADL.Y Average Weekly Movement11.2%
Consumer Retailing Industry Average Movement6.6%
Market Average Movement7.2%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: RADL.Y has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: RADL.Y's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190575,190Renato Raduanrdsaude.com.br

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

Raia Drogasil S.A. Fundamentals Summary

How do Raia Drogasil's earnings and revenue compare to its market cap?
RADL.Y fundamental statistics
Market capUS$5.66b
Earnings (TTM)US$251.27m
Revenue (TTM)US$8.78b
22.5x
P/E Ratio
0.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RADL.Y income statement (TTM)
RevenueR$45.55b
Cost of RevenueR$32.01b
Gross ProfitR$13.54b
Other ExpensesR$12.23b
EarningsR$1.30b

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Aug 04, 2026

Earnings per share (EPS)0.75
Gross Margin29.72%
Net Profit Margin2.86%
Debt/Equity Ratio49.9%

How did RADL.Y perform over the long term?

See historical performance and comparison

Dividends

2.3%
Current Dividend Yield
41%
Payout Ratio

Does RADL.Y pay a reliable dividends?

See RADL.Y dividend history and benchmarks
When do you need to buy RADL.Y by to receive an upcoming dividend?
Raia Drogasil dividend dates
Ex Dividend DateApr 13 2026
Dividend Pay DateDec 11 2026
Days until Ex dividend73 days
Days until Dividend pay date169 days

Does RADL.Y pay a reliable dividends?

See RADL.Y dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/23 10:09
End of Day Share Price 2026/06/23 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Raia Drogasil S.A. is covered by 22 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andréa AznarBB Banco de Investimento S.A.
Robert Ford AguilarBofA Global Research
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários